Search results (41)
« Back to PublicationsiNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.
Journal article
Diotallevi M. et al, (2026), Nat Metab
Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
Journal article
Purvis GSD. et al, (2025), Diabetologia, 68
Retraction: X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure.
Journal article
Frontiers Editorial Office ., (2025), Front Immunol, 16
Correction: RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance.
Journal article
Chen J. et al, (2025), Front Immunol, 16
Ly6Chi Monocytes Are Metabolically Reprogrammed in the Blood during Inflammatory Stimulation and Require Intact OxPhos for Chemotaxis and Monocyte to Macrophage Differentiation.
Journal article
Purvis GSD. et al, (2024), Cells, 13
Drug repurposing screen identifies novel anti-inflammatory activity of sunitinib in macrophages.
Journal article
Chaffey LE. et al, (2024), Eur J Pharmacol, 969
OxPhos in adipose tissue macrophages regulated by BTK enhances their M2-like phenotype and confers a systemic immunometabolic benefit in obesity.
Journal article
Purvis GSD. et al, (2024), Diabetes
Multityrosine kinase inhibitor sunitinib has anti-inflammatory activity in macrophages mediated via inhibition of NF-κB
Conference paper
Chaffey L. et al, (2023), BRITISH JOURNAL OF PHARMACOLOGY, 180, 536 - 537
Bruton's TK regulates myeloid cell recruitment during acute inflammation.
Journal article
Purvis GSD. et al, (2022), Br J Pharmacol, 179, 2754 - 2770
A Human CD68 Promoter-Driven Inducible Cre-Recombinase Mouse Line Allows Specific Targeting of Tissue Resident Macrophages.
Journal article
Rumianek AN. et al, (2022), Front Immunol, 13
Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues.
Journal article
Sheikh MH. et al, (2022), FASEB J, 36
Selected Abstracts from Pharmacology 2021.
Conference paper
(2021), Br J Pharmacol, 178, 4923 - 5006
